| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Synthesis, crystal structure and biological activity of beta-carboline based selective CDK4-cyclin D1 inhibitors. | Org Biomol Chem | 2006 | 0.97 |
| 2 | Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4. | Bioorg Med Chem | 2008 | 0.88 |
| 3 | Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1. | Bioorg Med Chem | 2009 | 0.87 |
| 4 | Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation. | Oncol Rep | 2009 | 0.86 |
| 5 | New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity. | Chem Commun (Camb) | 2004 | 0.80 |
| 6 | Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin. | Org Biomol Chem | 2006 | 0.79 |